Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back
Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding a...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BARRICADE
evolutionary platform to predict breast cancer BC patients...
176K€
Cerrado
VPH-PRISM
Virtual Physiological Human Personalized Predictive Breast...
5M€
Cerrado
TIN2010-16556
SISTEMAS INTELIGENTES BIOINSPIRADOS APLICADOS A MEDICINA PER...
111K€
Cerrado
EU-TOPIA
EU TOPIA TOWARDS IMPROVED SCREENING FOR BREAST CERVICAL AN...
3M€
Cerrado
PERSIST
Patients centered SurvivorShIp care plan after Cancer treatm...
5M€
Cerrado
Información proyecto BOUNCE
Duración del proyecto: 54 meses
Fecha Inicio: 2017-10-16
Fecha Fin: 2022-04-30
Líder del proyecto
HUSYHTYMA
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
5M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict resilience of women to the variety of stressful experiences and practical challenges related to breast cancer. This is a necessary step toward efficient recovery through personalized interventions. BOUNCE will bring together modeling, medical, and social sciences experts to advance current knowledge on the dynamic nature of resilience as it relates to efficient recovery from breast cancer. BOUNCE will take into consideration clinical, cancer-related biological, lifestyle, and psychosocial parameters in order to predict individual resilience trajectories throughout the cancer continuum and eventually increase resilience in breast cancer survivors and help them remain in the workforce and enjoy a better quality of life.
BOUNCE will deliver a unified clinical model of modifiable factors associated with optimal disease outcomes and will deploy a prospective multi-center clinical pilot at four major oncology centers (in Italy, Finland, Israel and Portugal), where a total of 660 women will be recruited in order to assess its clinical validity against crucial patient outcomes (illness progression, wellbeing, and functionality). The advanced computational tools to be employed will validate indices of patients’ capacity to bounce back during the highly stressful treatment and recovery period following diagnosis of breast cancer. The overreaching goal of BOUNCE is to incorporate elements of a dynamic, predictive model of patient outcomes in building a decision-support system used in routine clinical practice to provide physicians and other health professionals with concrete, personalized recommendations regarding optimal psychosocial support strategies.